BlackRock Portfolio Management LLC has filed an amendment to a Schedule 13G/A, indicating beneficial ownership of 2,508,488 shares of Vanda Pharmaceut...
Bullish
Vanda Pharmaceuticals Inc. has appointed Dr. Charles Duncan to its Board of Directors, effective April 22, 2026. Dr. Duncan brings over 30 years of ex...
Vanda Pharmaceuticals Inc. Senior VP and Medical Director, Christos Vasilios Mihael Polymeropoulos, has filed an initial ownership report detailing hi...
![[Form 3] Vanda Pharmaceuticals Inc. Initial Statement of Beneficial Ownership](https://www.stocktitan.net/img/logo/stock-titan-logo-header-free.png){kind=logo}
Neutral
Vanda Pharmaceuticals' VP and Chief People Officer, Howell Scott Laverne, has filed an initial ownership report (Form 3) detailing his holdings in the...